Five States Now Bar AI Chatbots From Practicing Therapy, and More Are Writing the Rules
Illinois, Nevada, Rhode Island and Maine now ban AI chatbots from practicing therapy outright, while Utah, California and Colorado are instead forcing chatbots to disclose they're not human — a patchwork that's reshaping how AI mental-health apps operate state by state.
After a Decade of Delays, Johnson & Johnson’s Ottava Surgical Robot Finally Wins FDA Approval
Johnson & Johnson's Ottava surgical robot finally won FDA authorization in July 2026 after more than a decade of delays, entering a soft-tissue robotic surgery market suddenly crowded with new AI-guided rivals.
Eli Lilly Fires Up World’s Most Powerful Pharma Supercomputer to Hunt for New Drugs
Eli Lilly has switched on LillyPod, a 1,016-GPU NVIDIA supercomputer delivering over 9,000 petaflops — a bet that owning frontier-scale AI compute is now essential to compete in drug discovery.
Schrodinger Spins Off a New Biotech Built Entirely Around Its AI Drug-Design Software
Schrodinger has co-founded Tectora Therapeutics, a $55 million Series A-backed biotech built to develop two of its own AI-designed drug candidates for immunology and inflammation.
Google’s Mammography AI Beats Human Readers in Largest NHS Breast Cancer Trial Yet
A Nature Cancer study spanning over 125,000 mammograms found Google's AI outperformed human radiologists on sensitivity while matching them on specificity — the largest NHS test yet of AI in breast cancer screening.
First Health Systems Earn URAC’s New AI Accreditation, Setting a National Bar for ‘Responsible AI’
Guidehealth, RediMinds and SandsRx are the first organizations to earn URAC's new Health Care AI Accreditation, a voluntary credential meant to fill the gap regulators haven't closed.
Qure.ai’s Chest X-Ray AI Wins Six New FDA Clearances, Taking the Crown in Radiology
Qure.ai's qXR-Detect just won six new FDA clearances for chest X-ray findings, becoming the first such tool cleared with a plan to keep updating its algorithm without a new filing each time.
Novo Nordisk Bets on AWS and Agentic AI to Cut Years Off Drug Discovery
Novo Nordisk has named AWS its preferred cloud and AI partner and opened a co-innovation hub in London, using tools like Amazon Bio Discovery and Bedrock to try to compress the path from drug target to first human dose, part of a broader wave of pharma-hyperscaler AI deals.
Oracle’s New AI Patient Portal Explains Your Cholesterol Trends in Plain English
Oracle Health's AI-powered patient portal, now generally available across the US, lets patients ask plain-language questions about labs, medications and diabetes management directly from their EHR, with citations and highlighting meant to keep AI answers traceable rather than opaque.